25 Feb, 2025 CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial Carlos Bonilla2025-07-19T20:00:14+00:00February 25th, 2025| Read More
13 Feb, 2025 CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina Carlos Bonilla2025-07-19T20:08:17+00:00February 13th, 2025| Read More
05 Feb, 2025 CereVasc, Inc. Announces Results of Groundbreaking Clinical Study of the eShunt® System in the Treatment of Elderly Patients with Normal Pressure Hydrocephalus Carlos Bonilla2025-07-19T20:10:54+00:00February 5th, 2025| Read More
